Pasithea Therapeutics Corp.
KTTA
$0.58
$0.00-0.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.73M | -20.43M | -13.49M | -13.46M | -13.61M |
| Total Depreciation and Amortization | 658.30K | 663.20K | 668.00K | 648.70K | 649.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.44M | 4.87M | 320.70K | 429.90K | 560.70K |
| Change in Net Operating Assets | -1.31M | -318.50K | 248.20K | -109.70K | -260.80K |
| Cash from Operations | -16.94M | -15.21M | -12.26M | -12.49M | -12.66M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 11.00K | 11.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 11.00K | 11.00K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -179.30K | -179.30K | -179.30K | -179.30K |
| Issuance of Common Stock | 62.31M | 63.97M | 7.51M | 7.51M | 1.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -268.90K | -268.90K | -253.50K | 4.40M | 4.52M |
| Cash from Financing | 62.05M | 63.52M | 7.07M | 11.73M | 5.99M |
| Foreign Exchange rate Adjustments | 46.90K | 18.80K | 46.40K | 6.60K | -1.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.16M | 48.34M | -5.14M | -750.50K | -6.67M |